Irisin improves delayed bone repair in diabetic female mice

[1]  Yuya Mizukami,et al.  Renal failure suppresses muscle irisin expression, and irisin blunts cortical bone loss in mice , 2022, Journal of cachexia, sarcopenia and muscle.

[2]  E. Morgan,et al.  Roles and Mechanisms of Irisin in Attenuating Pathological Features of Osteoarthritis , 2021, Frontiers in Cell and Developmental Biology.

[3]  Katsu Takahashi,et al.  Local application of Usag-1 siRNA can promote tooth regeneration in Runx2-deficient mice , 2021, Scientific Reports.

[4]  Yuya Mizukami,et al.  Role of irisin in effects of chronic exercise on muscle and bone in ovariectomized mice , 2021, Journal of Bone and Mineral Metabolism.

[5]  Yiqi Yang,et al.  Irisin inhibits osteocyte apoptosis by activating the Erk signaling pathway in vitro and attenuates ALCT-induced osteoarthritis in mice. , 2020, Bone.

[6]  B. Spiegelman,et al.  Irisin directly stimulates osteoclastogenesis and bone resorption in vitro and in vivo , 2020, bioRxiv.

[7]  Dongjun Liu,et al.  Cleavage of FNDC5 and insights into its maturation process , 2020, Molecular and Cellular Endocrinology.

[8]  K. Okada,et al.  PAI-1 is involved in delayed bone repair induced by glucocorticoids in mice. , 2020, Bone.

[9]  Chaofei Yang,et al.  Recombinant Irisin Prevents the Reduction of Osteoblast Differentiation Induced by Stimulated Microgravity through Increasing β-Catenin Expression , 2020, International journal of molecular sciences.

[10]  S. Colucci,et al.  Irisin Prevents Disuse‐Induced Osteocyte Apoptosis , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  M. Akagi,et al.  Role of irisin in androgen-deficient muscle wasting and osteopenia in mice , 2019, Journal of Bone and Mineral Metabolism.

[12]  X. Qiao,et al.  Lower circulating irisin in middle-aged and older adults with osteoporosis: a systematic review and meta-analysis. , 2019, Menopause.

[13]  Rui Li,et al.  Irisin Is Controlled by Farnesoid X Receptor and Regulates Cholesterol Homeostasis , 2019, Front. Pharmacol..

[14]  Xinquan Jiang,et al.  Delivery vehicle of muscle-derived irisin based on silk/calcium silicate/sodium alginate composite scaffold for bone regeneration , 2019, International journal of nanomedicine.

[15]  B. Spiegelman,et al.  Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors , 2018, Cell.

[16]  Yaxian Ma,et al.  Irisin promotes proliferation but inhibits differentiation in osteoclast precursor cells , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  K. Okada,et al.  Role of Macrophages and Plasminogen Activator Inhibitor-1 in Delayed Bone Repair in Diabetic Female Mice. , 2018, Endocrinology.

[18]  Xu Zhou,et al.  Association of Plasma Irisin with Bone Mineral Density in a Large Chinese Population Using an Extreme Sampling Design , 2018, Calcified Tissue International.

[19]  K. Okada,et al.  Role of plasminogen activator inhibitor ‐ 1 in glucocorticoid ‐ induced muscle change in mice , 2017 .

[20]  N. Kawao,et al.  Roles of Irisin in the Linkage from Muscle to Bone During Mechanical Unloading in Mice , 2018, Calcified Tissue International.

[21]  Jiake Xu,et al.  TNF-α inhibits SATB2 expression and osteoblast differentiation through NF-κB and MAPK pathways , 2017, Oncotarget.

[22]  J. Reseland,et al.  Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice , 2017, Scientific Reports.

[23]  D. Jiang,et al.  High glucose‐induced LIF suppresses osteoblast differentiation via regulating STAT3/SOCS3 signaling , 2017, Cytokine.

[24]  N. Kawao,et al.  Vitamin D deficiency aggravates diabetes-induced muscle wasting in female mice , 2017, Diabetology International.

[25]  H. Kaji.  Effects of myokines on bone. , 2016, BoneKEy reports.

[26]  B. Olsen,et al.  Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair. , 2016, The Journal of clinical investigation.

[27]  R. Cheng,et al.  Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways , 2016, Scientific Reports.

[28]  T. Yuen,et al.  The myokine irisin increases cortical bone mass , 2015, Proceedings of the National Academy of Sciences.

[29]  Qian Zhao,et al.  Decreased irisin secretion contributes to muscle insulin resistance in high-fat diet mice. , 2015, International journal of clinical and experimental pathology.

[30]  P. Matafome,et al.  Irisin and Myonectin Regulation in the Insulin Resistant Muscle: Implications to Adipose Tissue: Muscle Crosstalk , 2015, Journal of diabetes research.

[31]  N. Kawao,et al.  Interactions Between Muscle Tissues and Bone Metabolism , 2015, Journal of cellular biochemistry.

[32]  Y. Chiba,et al.  Role of PlasminogenActivator Inhibitor-1 in Glucocorticoid-Induced Diabetes and Osteopenia in Mice , 2015 .

[33]  K. Okada,et al.  Plasminogen Activator Inhibitor-1 Is Involved in Impaired Bone Repair Associated with Diabetes in Female Mice , 2014, PloS one.

[34]  C. Mantzoros,et al.  Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months , 2014, Osteoporosis International.

[35]  S. Colucci,et al.  Irisin Enhances Osteoblast Differentiation In Vitro , 2014, International journal of endocrinology.

[36]  I. Kanazawa,et al.  Advanced glycation end products suppress osteoblastic differentiation of stromal cells by activating endoplasmic reticulum stress. , 2013, Biochemical and biophysical research communications.

[37]  Lutz Claes,et al.  Fracture healing under healthy and inflammatory conditions , 2012, Nature Reviews Rheumatology.

[38]  B. Spiegelman,et al.  A PGC1α-dependent myokine that drives browning of white fat and thermogenesis , 2012, Nature.

[39]  J. J. Swaroop,et al.  Association of TNF-α with insulin resistance in type 2 diabetes mellitus , 2012, The Indian journal of medical research.

[40]  N. Donos,et al.  The effect of diabetes mellitus on osseous healing. , 2010, Clinical oral implants research.

[41]  L. McCabe.  Understanding the pathology and mechanisms of type I diabetic bone loss , 2007, Journal of cellular biochemistry.

[42]  P. Vestergaard,et al.  Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis , 2007, Osteoporosis International.

[43]  Sheldon S. Lin,et al.  The effects of local insulin delivery on diabetic fracture healing. , 2005, Bone.

[44]  Shingo,et al.  A PGC1-\(\alpha\)-dependent Myokine that Drives Brown-fat-like Development of White Fat and Thermogenesis , 2012 .

[45]  C. Ackert-Bicknell,et al.  Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. , 2009, Critical reviews in eukaryotic gene expression.